Copyright
©The Author(s) 2021.
World J Clin Cases. Nov 6, 2021; 9(31): 9607-9616
Published online Nov 6, 2021. doi: 10.12998/wjcc.v9.i31.9607
Published online Nov 6, 2021. doi: 10.12998/wjcc.v9.i31.9607
Table 1 Therapy course
| Date | Low-molecular-weight heparin | Pegaspargase | Cyclophosphamide | Pegylated liposomal doxorubicin | Vindesine | Dexamethasone | Methotrexate | Chidamide |
| July 16-July 19 | 5000 U/d | 5 mg/d | ||||||
| July 20-July 26 | 3750 IU × 1 d | 1.2 g × 1 d | 20 mg/d × 3 d | 4 mg × 1 d | 10 mg/d × 7 d | |||
| August 23-August 29 | 3750 IU × 1 d | 1.0 g × 1 d | 20 mg/d × 3 d | 4 mg × 1 d | 10 mg/d × 7 d | 2 g × 1 d | ||
| September 20 | 30 mg 2/wk (follow up for half year) | |||||||
- Citation: Ma YY, Zhang QC, Tan X, Zhang X, Zhang C. T-cell lymphoblastic lymphoma with extensive thrombi and cardiac thrombosis: A case report and review of literature. World J Clin Cases 2021; 9(31): 9607-9616
- URL: https://www.wjgnet.com/2307-8960/full/v9/i31/9607.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v9.i31.9607